{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:01:39Z","timestamp":1791309699316,"version":"4.3.1"},"reference-count":40,"publisher":"European Respiratory Society (ERS)","issue":"3","license":[{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["ERJ Open Res"],"accepted":{"date-parts":[[2025,10,17]]},"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Understanding the prevalence of pneumococcal serotypes in hospitalised patients with community-acquired pneumonia (CAP) is critical for vaccine development and implementation of future public health policies. Pneumococcal conjugate vaccines (PCVs) have been implemented to decrease the burden of pneumococcal disease. This study aims to identify the serotype distribution of pneumococcal CAP in Germany.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This interim analysis of a multicentre, prospective, active observational study includes patients aged \u226518\u2005years hospitalised with CAP in seven German hospitals. Patients were enrolled between August 2022 and September 2024. To determine CAP aetiology, microbiological tests were performed according to local standard of care. Urinary antigen testing for\n                      <jats:italic>Streptococcus pneumoniae<\/jats:italic>\n                      (BinaxNOW) was performed in all patients, and two serotype-specific urinary antigen detection (SSUAD) assays were used to detect serotypes in pneumococcal vaccines PCV15 and PCV20.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      <jats:italic>S. pneumoniae<\/jats:italic>\n                      was detected in 16.5% (85\/514) of participants by all diagnostic tests. SSUAD assays detected\n                      <jats:italic>S. pneumoniae<\/jats:italic>\n                      as pathogen in 13.2% (68\/514) of participants. In six patients, two pneumococcal serotypes were detected. The seven most detected serotypes were: 3, 11A, 8, 23B, 9N, 18C and 22F. Among 74 serotype detections, 64 (86.9%) are included in V116 compared with 56 (75.8%) in PCV20. The difference in coverage between PCV20 and V116 was 10.8% (95% CI \u22123.2\u201324.8%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Among adults hospitalised with CAP in Germany,\n                      <jats:italic>S. pneumoniae<\/jats:italic>\n                      was detected in 13% of cases by SSUAD assays. While the findings suggest that V116 may offer broader serotype coverage compared with PCV20, these differences were not statistically significant.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1183\/23120541.00946-2025","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T16:55:15Z","timestamp":1764262515000},"page":"00946-2025","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Serotype distribution and coverage by pneumococcal vaccines in hospitalised adults with pneumococcal pneumonia in Germany"],"prefix":"10.1183","volume":"12","author":[{"given":"Dian","family":"Karssen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"Hessels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grit","family":"Barten-Neiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Franch-Arroyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"F\u00fchner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina O.","family":"Hassiepen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David F.","family":"Heigener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiaan","family":"Hullegie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rianne","family":"Jahja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4275-6135","authenticated-orcid":false,"given":"Kelly D.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julius","family":"Kremling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8157-2753","authenticated-orcid":false,"given":"Mathias W.","family":"Pletz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig S.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5193-7755","authenticated-orcid":false,"given":"Gernot G.U.","family":"Rohde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madelyn","family":"Ruggieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0099-882X","authenticated-orcid":false,"given":"Daiana","family":"Stolz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd D.","family":"Swarthout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0626-4635","authenticated-orcid":false,"given":"Cornelis H.","family":"Van Werkhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9787-5633","authenticated-orcid":false,"given":"Martin","family":"Witzenrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc J.M.","family":"Bonten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6974-9165","authenticated-orcid":false,"given":"Cristina","family":"Prat Aymerich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2025,11,27]]},"reference":[{"key":"2026050501500903000_12.3.00946-2025.1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41572-021-00259-0","article-title":"Pneumonia","volume":"7","author":"Torres","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"2026050501500903000_12.3.00946-2025.2","unstructured":"Institute for Health Metrics and Evaluation . Global Burden of Disease Study 2021 (GBD 2021) Lower Respiratory Infections and Aetiologies Incidence and Mortality Estimates 1990\u20132021. Seattle, Institute for Health Metrics and Evaluation, 2024."},{"key":"2026050501500903000_12.3.00946-2025.3","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2015-206780"},{"key":"2026050501500903000_12.3.00946-2025.4","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2009.129502"},{"key":"2026050501500903000_12.3.00946-2025.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1500245"},{"key":"2026050501500903000_12.3.00946-2025.6","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-75691-5"},{"key":"2026050501500903000_12.3.00946-2025.7","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/joim.12956","article-title":"The changing epidemiology of community-acquired pneumonia: nationwide register-based study in Sweden","volume":"286","author":"Naucler","year":"2019","journal-title":"J Intern Med"},{"key":"2026050501500903000_12.3.00946-2025.8","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2019-213725"},{"key":"2026050501500903000_12.3.00946-2025.9","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejim.2016.12.010","article-title":"Trends in hospitalizations for community-acquired pneumonia in Spain: 2004 to 2013","volume":"40","author":"de Miguel-D\u00edez","year":"2017","journal-title":"Eur J Intern Med"},{"key":"2026050501500903000_12.3.00946-2025.10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01366"},{"key":"2026050501500903000_12.3.00946-2025.11","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1080\/21645515.2016.1264548","article-title":"Herd effects of child vaccination with pneumococcal conjugate vaccine against pneumococcal non-invasive community-acquired pneumonia: what is the evidence?","volume":"13","author":"van Werkhoven","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"2026050501500903000_12.3.00946-2025.12","doi-asserted-by":"crossref","first-page":"e744","DOI":"10.1016\/S2214-109X(18)30247-X","article-title":"Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000\u201315","volume":"6","author":"Wahl","year":"2018","journal-title":"Lancet Glob Health"},{"key":"2026050501500903000_12.3.00946-2025.13","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30052-5"},{"key":"2026050501500903000_12.3.00946-2025.14","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1093\/infdis\/jiad538","article-title":"Potential impact of higher-valency pneumococcal conjugate vaccines among adults in different localities in Germany","volume":"229","author":"Ellingson","year":"2024","journal-title":"J Infect Dis"},{"key":"2026050501500903000_12.3.00946-2025.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.11.026"},{"key":"2026050501500903000_12.3.00946-2025.16","doi-asserted-by":"crossref","first-page":"100126","DOI":"10.1016\/j.lanepe.2021.100126","article-title":"Pneumococcal vaccine uptake and vaccine effectiveness in older adults with invasive pneumococcal disease in Germany: a retrospective cohort study","volume":"7","author":"Perniciaro","year":"2021","journal-title":"Lancet Reg Health Eur"},{"key":"2026050501500903000_12.3.00946-2025.17","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-0941-9"},{"key":"2026050501500903000_12.3.00946-2025.18","unstructured":"Robert Koch Institute . Epidemiologisches Bulletin 39. STIKO: Aktualisierung der Empfehlungen zur Pneumokokken-Impfung. [Epidemiological Bulletin 39. STIKO: Update of recommendations on pneumococcal vaccination.] 2023. www.rki.de\/DE\/Aktuelles\/Publikationen\/Epidemiologisches-Bulletin\/2023\/39_23.html Date last accessed: 26 December 2025."},{"key":"2026050501500903000_12.3.00946-2025.19","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02432-2021"},{"key":"2026050501500903000_12.3.00946-2025.20","doi-asserted-by":"crossref","first-page":"793","DOI":"10.15585\/mmwr.mm7336a3","article-title":"Use of 21-valent pneumococcal conjugate vaccine among U.S. adults: recommendations of the advisory committee on immunization practices \u2013 United States, 2024","volume":"73","author":"Kobayashi","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2026050501500903000_12.3.00946-2025.21","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S1473-3099(24)00344-X","article-title":"Safety, tolerability, and immunogenicity of an adult pneumococcal conjugate vaccine, V116 (STRIDE-3): a randomised, double-blind, active comparator controlled, international phase 3 trial","volume":"24","author":"Platt","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"2026050501500903000_12.3.00946-2025.22","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1093\/cid\/ciae383","article-title":"A phase 3 clinical study to evaluate the safety, tolerability, and immunogenicity of V116 in pneumococcal vaccine-experienced adults 50 years of age or older (STRIDE-6)","volume":"79","author":"Scott","year":"2024","journal-title":"Clin Infect Dis"},{"key":"2026050501500903000_12.3.00946-2025.23","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00703-2022"},{"key":"2026050501500903000_12.3.00946-2025.24","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-0803-5"},{"key":"2026050501500903000_12.3.00946-2025.25","doi-asserted-by":"crossref","first-page":"e0011422","DOI":"10.1128\/msphere.00114-22","article-title":"Development and validation of a sensitive and robust multiplex antigen capture assay to quantify Streptococcus pneumoniae serotype-specific capsular polysaccharides in urine","volume":"7","author":"Rajam","year":"2022","journal-title":"mSphere"},{"key":"2026050501500903000_12.3.00946-2025.26","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1080\/17576180.2024.2357030","article-title":"Qualification of a 21-valent pneumococcal urine antigen detection assay and development of clinical positivity cutoffs","volume":"16","author":"Choudhury","year":"2024","journal-title":"Bioanalysis"},{"key":"2026050501500903000_12.3.00946-2025.27","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00237-2025"},{"key":"2026050501500903000_12.3.00946-2025.28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199701233360402"},{"key":"2026050501500903000_12.3.00946-2025.29","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.58.5.377"},{"key":"2026050501500903000_12.3.00946-2025.30","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201908-1581ST"},{"key":"2026050501500903000_12.3.00946-2025.31","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.232558"},{"key":"2026050501500903000_12.3.00946-2025.32","unstructured":"Castor EDC . Castor \u2013 Top-Rated eClinical Data Management Platform. 2019. https:\/\/castoredc.com Date last accessed: 26 December 2025."},{"key":"2026050501500903000_12.3.00946-2025.33","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00787-17"},{"key":"2026050501500903000_12.3.00946-2025.34","doi-asserted-by":"crossref","first-page":"e0011422","DOI":"10.1128\/msphere.00114-22","article-title":"Development and validation of a sensitive and robust multiplex antigen capture assay to quantify Streptococcus pneumoniae serotype-specific capsular polysaccharides in urine","volume":"7","author":"Rajam","year":"2022","journal-title":"mSphere"},{"key":"2026050501500903000_12.3.00946-2025.35","unstructured":"RStudio Team . RStudio: integrated development environment for R (Version 4.2.1). 2024. www.rstudio.com Date last accessed: 26 December 2025."},{"key":"2026050501500903000_12.3.00946-2025.36","unstructured":"ECDC . Invasive Pneumococcal Disease. Annual Epidemiological Report for 2018. Stockholm, European Centre for Disease Prevention and Control, 2020."},{"key":"2026050501500903000_12.3.00946-2025.37","doi-asserted-by":"publisher","DOI":"10.1055\/s-0032-1310103"},{"key":"2026050501500903000_12.3.00946-2025.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2017.08.010"},{"key":"2026050501500903000_12.3.00946-2025.39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0253118"},{"key":"2026050501500903000_12.3.00946-2025.40","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s10096-022-04416-5","article-title":"Early post-discharge mortality in CAP: frequency, risk factors and a prediction tool","volume":"41","author":"Gl\u00f6ckner","year":"2022","journal-title":"Eur J Clin Microbiol Infect Dis"}],"container-title":["ERJ Open Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/23120541.00946-2025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T08:50:21Z","timestamp":1777971021000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/23120541.00946-2025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":40,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,5,5]]},"published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1183\/23120541.00946-2025"],"URL":"https:\/\/doi.org\/10.1183\/23120541.00946-2025","relation":{},"ISSN":["2312-0541"],"issn-type":[{"value":"2312-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,27]]}}}